Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.31 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1003042 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL13843579 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL1004293 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL29521285 | 1.00 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| Sulfuric Acid SCHEMBL4926135 | 0.90 | MEN1 (0.41) | MEN1KMT2ATSHRMAPK1THRB | |
| Sulfuric Acid SCHEMBL4916797 | 0.90 | MEN1 (0.41) | MEN1KMT2ATSHRMAPK1THRB | |
| Sulfuric Acid SCHEMBL4917301 | 0.90 | MEN1 (0.41) | MEN1KMT2ATSHRMAPK1THRB | |
| Sulfuric Acid SCHEMBL4927490 | 0.90 | MEN1 (0.41) | MEN1KMT2ATSHRMAPK1THRB | |
| Sulfuric Acid SCHEMBL4925364 | 0.90 | MEN1 (0.41) | MEN1KMT2ATSHRMAPK1THRB | |
| Sulfuric Acid SCHEMBL4926032 | 0.90 | MEN1 (0.41) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11702429-B2 | mTORC modulators and uses thereof | AEOVIAN PHARMACEUTICALS, INC. (US) | 2023-07-18 | — | — | US | disclosed |
| CN-110536893-B | Disilanamine compounds, method of preparing the same, and silicon-containing thin film deposition composition including the same | DNF有限公司 | 2023-04-07 | — | — | CN | disclosed |
| US-20230051589-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS AG (CH) | 2023-02-16 | — | — | US | disclosed |
| US-20230013344-A1 | MTORC MODULATORS AND USES THEREOF | EVOTEC (FRANCE) SAS (FR) | 2023-01-19 | — | — | US | disclosed |
| WO-2022074999-A1 | SECONDARY BATTERY | 株式会社村田製作所 | 2022-04-14 | — | — | WO | disclosed |
| WO-2022054813-A1 | ELECTROCHEMICAL DEVICE | 株式会社村田製作所 | 2022-03-17 | — | — | WO | disclosed |
| US-11230557-B2 | mTORC modulators and uses thereof | AEOVIAN PHARMACEUTICALS, INC. (US) | 2022-01-25 | — | — | US | disclosed |
| CN-110546210-B | Silicon-containing film deposition composition including disilazane compound and method of preparing silicon-containing film using the same | DNF有限公司 | 2021-12-14 | — | — | CN | disclosed |
| US-20210008041-A1 | MTORC MODULATORS AND USES THEREOF | AEOVIAN PHARMACEUTICALS, INC. | 2021-01-14 | — | — | US | disclosed |
| CN-110546210-A | Silicon-containing film deposition composition including disilazane compound and method of preparing silicon-containing film using the same | DNF CO LTD | 2019-12-06 | — | — | CN | disclosed |
| US-7306664-B2 | Ink-jet recording ink, ink-jet recording method, and ink-jet recording apparatus | CANON KABUSHIKI KAISHA (JP) | 2007-12-11 | — | — | US | disclosed |
| WO-1996029502-A1 | HYDRATE INHIBITORS | BP EXPLORATION OPERATING COMPANY LIMITED (GB) | 1996-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702429-B2 | mTORC modulators and uses thereof | MTOR, RICTOR, RPTOR | MEN1 1893/4885KMT2A 3291/4885TSHR 3270/4885 |
| US-20230051589-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NLRP1, NLRP3, NOD1 | MEN1 3277/4885KMT2A 4465/4885TSHR 4306/4885 |
| US-20210008041-A1 | MTORC MODULATORS AND USES THEREOF | MTOR, RICTOR, RPTOR | MEN1 1893/4885KMT2A 3291/4885TSHR 3270/4885 |
| US-11230557-B2 | mTORC modulators and uses thereof | MTOR, RICTOR, RPTOR | MEN1 1893/4885KMT2A 3291/4885TSHR 3270/4885 |
| US-20230013344-A1 | MTORC MODULATORS AND USES THEREOF | MTOR, RICTOR, RPTOR | MEN1 1893/4885KMT2A 3291/4885TSHR 3270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.